A detailed history of Aristides Capital LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Aristides Capital LLC holds 11,900 shares of BNTX stock, worth $1.35 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
11,900
Previous 11,900 -0.0%
Holding current value
$1.35 Million
Previous $956,000 47.8%
% of portfolio
0.65%
Previous 0.44%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$90.91 - $112.75 $909,100 - $1.13 Million
10,000 Added 526.32%
11,900 $1.26 Million
Q4 2022

Feb 14, 2023

BUY
$118.43 - $186.05 $225,017 - $353,495
1,900 New
1,900 $285,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.5B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Aristides Capital LLC Portfolio

Follow Aristides Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristides Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristides Capital LLC with notifications on news.